Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

AS601245 (1,3-Benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) Acetonitrile): A c-Jun NH2-Terminal Protein Kinase Inhibitor with Neuroprotective Properties

Sonia Carboni, Agnes Hiver, Cedric Szyndralewiez, Pascale Gaillard, Jean-Pierre Gotteland and Pierre-Alain Vitte
Journal of Pharmacology and Experimental Therapeutics July 2004, 310 (1) 25-32; DOI: https://doi.org/10.1124/jpet.103.064246
Sonia Carboni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnes Hiver
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cedric Szyndralewiez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Gaillard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Pierre Gotteland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-Alain Vitte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 310 no. 1 25-32
DOI 
https://doi.org/10.1124/jpet.103.064246
PubMed 
14988419

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received December 11, 2003
  • Accepted February 25, 2004
  • Published online June 17, 2004.

Article Versions

  • Earlier version (February 26, 2004 - 11:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Sonia Carboni,
  2. Agnes Hiver,
  3. Cedric Szyndralewiez,
  4. Pascale Gaillard,
  5. Jean-Pierre Gotteland and
  6. Pierre-Alain Vitte
  1. Departments of Pharmacology (S.C., A.H., C.S., P.-A.V.) and Chemistry (P.G., J.-P.G.), Serono Pharmaceutical Research Institute, Geneva, Switzerland
  1. Address correspondence to:
    Dr. Pierre-Alain Vitte, Department of Pharmacology, Serono Pharmaceutical Research Institute, 14, Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland. E-mail: pierre-alain.vitte{at}serono.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2004 to December 2023

AbstractFullPdf
Feb 20041907
Mar 2004810182
Apr 200425043
May 200429035
Jun 200414257119
Jul 20041229397
Aug 2004986354
Sep 2004785953
Oct 2004814530
Nov 2004664234
Dec 2004572125
Jan 2005613542
Feb 2005625219
Mar 2005413432
Apr 2005375529
May 2005386033
Jun 2005294623
Jul 2005305231
Aug 2005243732
Sep 2005303026
Oct 2005302848
Nov 2005242536
Dec 2005443131
Jan 2006442725
Feb 2006463630
Mar 2006362731
Apr 2006252717
May 2006481433
Jun 2006212118
Jul 2006152015
Aug 2006292514
Sep 2006211841
Oct 2006222824
Nov 2006223035
Dec 2006261116
Jan 200791414
Feb 2007132323
Mar 2007202526
Apr 200751524
May 2007242822
Jun 2007242027
Jul 2007171617
Aug 2007192129
Sep 2007402849
Oct 2007261528
Nov 2007312114
Dec 2007271724
Jan 2008442647
Feb 2008231633
Mar 2008252730
Apr 2008271017
May 2008322133
Jun 2008273056
Jul 2008472131
Aug 2008952221
Sep 2008421813
Oct 2008521728
Nov 2008402222
Dec 2008121511
Jan 2009271715
Feb 2009512232
Mar 2009691237
Apr 2009531625
May 2009321325
Jun 200916916
Jul 2009231217
Aug 2009221520
Sep 20092939
Oct 2009501223
Nov 2009601424
Dec 200951533
Jan 201023717
Feb 2010241019
Mar 201028721
Apr 2010171511
May 2010151812
Jun 201017413
Jul 20106914
Aug 20106912
Sep 20109414
Oct 2010132114
Nov 20108139
Dec 201015129
Jan 201151113
Feb 201110917
Mar 2011132516
Apr 201191313
May 2011211326
Jun 2011171128
Jul 2011141319
Aug 2011151718
Sep 2011151324
Oct 2011181324
Nov 2011181016
Dec 2011141016
Jan 201213921
Feb 2012131222
Mar 2012141223
Apr 2012161223
May 2012121719
Jun 201212421
Jul 2012251926
Aug 201212811
Sep 201214918
Oct 201291515
Nov 2012121315
Dec 2012151225
Jan 2013181423
Feb 2013151514
Mar 201310616
Apr 201312717
May 2013181127
Jun 201371418
Jul 2013488
Aug 20135710
Sep 2013454
Oct 2013121210
Nov 201382410
Dec 20131387
Jan 20147128
Feb 2014111318
Mar 201411242
Apr 20148349
May 201410912
Jun 201411712
Jul 2014281517
Aug 201462012
Sep 2014111112
Oct 20149158
Nov 2014463
Dec 2014945
Jan 20159910
Feb 2015173
Mar 2015967
Apr 20156125
May 2015131016
Jun 2015545
Jul 201561410
Aug 20159911
Sep 201510115
Oct 2015414
Nov 20151877
Dec 20151066
Jan 201622136
Feb 2016656
Mar 2016319
Apr 2016221
May 2016767
Jun 2016834
Jul 2016642
Aug 2016789
Sep 201691213
Oct 201641211
Nov 2016283
Dec 20161112
Jan 20172217
Feb 20172243
Mar 20173285
Apr 20172196
May 20172215
Jun 20172140
Jul 20175258
Aug 20172306
Sep 201732412
Oct 20174222
Nov 201701511
Dec 20171138
Jan 20181147
Feb 20184149
Mar 201831110
Apr 201812615
May 20181208
Jun 201816813
Jul 201821618
Aug 20180105
Sep 20180227
Oct 20181225
Nov 2018105716
Dec 20181331
Jan 20192913
Feb 20192710
Mar 20192226
Apr 2019943
May 20192435
Jun 20191022
Jul 20191332
Aug 20194026
Sep 20195932
Oct 20191612
Nov 20191913
Dec 20192551
Jan 20201123
Feb 20201510
Mar 20201001
Apr 2020611
May 2020931
Jun 20201510
Jul 20202511
Aug 2020515
Sep 2020810
Oct 2020613
Nov 20202223
Dec 20202023
Jan 20212213
Feb 20211812
Mar 20212381
Apr 20211631
May 20213887
Jun 2021714
Jul 20212724
Aug 20211611
Sep 20212853
Oct 20213444
Nov 20211832
Dec 20212112
Jan 202216210
Feb 2022841
Mar 20221040
Apr 20222718
May 20224224
Jun 20221822
Jul 20223216
Aug 20221116
Sep 20222417
Oct 20222311
Nov 20222224
Dec 20221410
Jan 20232623
Feb 20231710
Mar 20231812
Apr 2023934
May 20231345
Jun 20231220
Jul 20233048
Aug 20231515
Sep 20231120
Oct 20232338
Nov 20231733
Dec 20231011

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 310 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 1
1 Jul 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
AS601245 (1,3-Benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) Acetonitrile): A c-Jun NH2-Terminal Protein Kinase Inhibitor with Neuroprotective Properties
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

AS601245 (1,3-Benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) Acetonitrile): A c-Jun NH2-Terminal Protein Kinase Inhibitor with Neuroprotective Properties

Sonia Carboni, Agnes Hiver, Cedric Szyndralewiez, Pascale Gaillard, Jean-Pierre Gotteland and Pierre-Alain Vitte
Journal of Pharmacology and Experimental Therapeutics July 1, 2004, 310 (1) 25-32; DOI: https://doi.org/10.1124/jpet.103.064246

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

AS601245 (1,3-Benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) Acetonitrile): A c-Jun NH2-Terminal Protein Kinase Inhibitor with Neuroprotective Properties

Sonia Carboni, Agnes Hiver, Cedric Szyndralewiez, Pascale Gaillard, Jean-Pierre Gotteland and Pierre-Alain Vitte
Journal of Pharmacology and Experimental Therapeutics July 1, 2004, 310 (1) 25-32; DOI: https://doi.org/10.1124/jpet.103.064246
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Novel Neuroprotectant Neurosteroids for OP Intoxication
  • Disease-Modifying Effects of Neurosteroids in Post-SE Models
  • Lacosamide and Rufinamide Against SE
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics